For the quarter ending 2025-10-31, PURE made $708K in revenue. -$464K in net income. Net profit margin of -65.54%.
| Income Statement | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-10-31 |
|---|---|---|---|---|
| Total revenue | 708 | 578 | 491 | 556 |
| Cost of goods sold | 258 | 230 | 208 | 231 |
| Gross profit | 450 | 348 | 283 | 325 |
| Selling, general and administrative | 743 | 801 | 776 | 881 |
| Research and development | 86 | 77 | 91 | 71 |
| Total operating costs and expenses | 829 | 878 | 867 | 952 |
| Loss from operations | -379 | -530 | -584 | -627 |
| Interest expense, net | 94 | 80 | 78 | 62 |
| Other income, net | 9 | 46 | 82 | - |
| Total other income (expense) | -85 | -34 | 4 | -62 |
| Net loss | -464 | -565 | -580 | -689 |
| Basic net loss per share | 0 | 0 | -0.01 | -0.01 |
| Diluted net loss per share | 0 | 0 | -0.01 | -0.01 |
| Shares used in computing basic net loss per share | 111,886,473 | -55,925,031 | 111,856,473 | 111,856,473 |
| Shares used in computing diluted net loss per share | 111,886,473 | -55,925,031 | 111,856,473 | 111,856,473 |
PURE BIOSCIENCE, INC. (PURE)
PURE BIOSCIENCE, INC. (PURE)